Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 163, pseudogene (abbreviated RNU6-163P) is a genomic sequence classified as a **pseudogene** of the U6 small nuclear RNA gene family[1]. Pseudogenes are DNA sequences that resemble functional genes but typically do not encode functional products[1]. RNU6-163P is neither protein-coding nor known to be transcribed into a functional RNA[1]. The canonical U6 small nuclear RNA (snRNA) is an essential part of the eukaryotic spliceosome, involved in pre-mRNA splicing[2][3]; however, **RNU6-163P does not contribute to those functions, nor is it classified as a therapeutic target, receptor, enzyme, transporter, or related molecular entity in drug discovery or therapeutic intervention**[1].
null (no mechanism of action, not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 163, pseudogene (RNU6-163P).